Homepage > Rare diseases > Search

Search for a rare disease

*
(*) mandatory field

Primary angiitis of the central nervous system

Suggest an update
Your message has been sent Your message has not been sent. Please contact an administrator.
Disease definition

A rare, medium or small vessel vasculitis characterized by focal and/or diffuse neurologic symptoms due to a documented arteritic process in the central nervous system, in the absence of other identified underlying cause (infectious, systemic, other neurologic diseases, etc.). It presents with non-specific symptoms of headache, stroke or transient ischemic attacks with cognitive impairment, hemiplegia, weakness, and rarely, with cranial nerve involvement, seizures and ataxia.

ORPHA:140989

Classification level: Disorder

Synonym(s):
  • Isolated angiitis of the central nervous system
  • PACNS
  • PCNSV
  • Primary central nervous system vasculitis
  • Primary vasculitis of the central nervous system

Prevalence: Unknown

Inheritance: Not applicable

Age of onset: All ages

ICD-10: I67.7

ICD-11: 4A44.7

UMLS: C2930862

MeSH: C535276

GARD: 8703

Summary
Epidemiology

The prevalence is unknown, but it is estimated to account for 1% of the systemic vasculitides.

Clinical description

Primary angiitis of the central nervous system (PACNS) usually affects middle-aged adults (mean age 51 years). Clinical presentation is variable, ranging from hyper acute to chronic and insidious, but typically has a progressive clinical evolution. The most common symptom is headache, variable in description but very rarely a thunderclap headache. Other symptoms include cognitive impairment (usually insidious), stroke (typically multiple, occurring over a (long) period and affecting different areas of the vascular bed) and transient ischemic attacks. Rarely, cranial nerve involvement, myelopathy, seizures or ataxia are observed. Associated angiographic abnormalities are common, cerebral MRI is almost invariably abnormal with nonspecific findings (including, rarely, solitary mass lesion), and cerebrospinal fluid (CSF) examination shows aseptic inflammatory abnormalities. Constitutional symptoms such as fever, weight loss and visceral organ involvement are rare and if present, should raise the suspicion of more systemic illnesses.

Etiology

The primary defect is unknown. Pathological inflammation process affecting the small and medium-sized cerebral vessels causes them to become narrowed, occluded and thrombosed, leading to tissue ischemia and necrosis of the territories of the involved vessels.

Diagnostic methods

Diagnosis of PACNS is established in a patient who: (i) has a history of unexplained neurologic deficit after thorough clinical and laboratory evaluation, (ii) has a documented (by cerebral angiography and/or tissue examination) of an arteritic process within the central nervous system, and (iii) no evidence of systemic vasculitis or any other condition to which the angiographic or pathological features could be secondary. Angiography abnormalities encountered in PACNS are characterized by irregular eccentric notched appearance with distal cutoffs and neovascularization, and typically asymmetric involvement. CSF findings resemble those of an aseptic meningitis with modest lymphocytic pleocytosis, normal glucose levels, elevated protein levels and, occasionally, the presence of oligoclonal bands and elevated IgG synthesis.

Differential diagnosis

Differential diagnosis of PACNS is extensive and challenging, and comprises a range of systemic inflammatory conditions, infections, conditions with cerebral angiographic abnormalities (in particular, reversible vasoconstriction syndrome (RCVS) has highly similar clinical presentation; however, the associated headache is predominantly thunderclap by quality), and other neoplastic, genetic or neurological conditions.

Management and treatment

Glucocorticoids combined with immunosuppressive agents, i.e. cyclophosphamide, has been successful in most cases. Accompanying prophylaxis for P. jirovecii and osteoporosis is necessary.

Prognosis

The disease is chronic and relapses are not uncommon.

Last update: October 2020 - Expert reviewer(s): Pr Xavier PUECHAL - Pr Benjamin TERRIER
A summary on this disease is available in Français, Español, Deutsch, Italiano, Nederlands Ελληνικά, Русский
Detailed information

Logo ERN: produced/endorsed by ERN(s) Logo FSMR: produced/endorsed by FSMR(s)

General public
Article for general public
Norsk (2016) - PRINTO/PRES
Français (2016) - PRINTO/PRES
עברית (2016) - PRINTO/PRES
Polski (2016) - PRINTO/PRES
Latviešu (2016) - PRINTO/PRES
Deutsch (2016) - PRINTO/PRES
Ελληνικά (2016) - PRINTO/PRES
English (2016) - PRINTO/PRES
Español (2016) - PRINTO/PRES
Nederlands (2016) - PRINTO/PRES
Türkçe (2016) - PRINTO/PRES
ไทย (2016) - PRINTO/PRES
বাংলা (2016) - PRINTO/PRES
Slovenščina (2016) - PRINTO/PRES
Slovenčina (2016) - PRINTO/PRES
Dansk (2016) - PRINTO/PRES
Српски (2016) - PRINTO/PRES
Čeština (2016) - PRINTO/PRES
Русский (2016) - PRINTO/PRES
Hrvatski (2016) - PRINTO/PRES
中文 (2016) - PRINTO/PRES
Română (2016) - PRINTO/PRES
Magyar (2016) - PRINTO/PRES
Italiano (2016) - PRINTO/PRES
العربية (2016) - PRINTO/PRES
Português (2016) - PRINTO/PRES
Guidelines
Emergency guidelines
Français (2021.pdf) - Orphanet Urgences
Clinical practice guidelines
Español (2020.pdf) - Asoc Española de Pediatría
Disease review articles
Review article
English (2024) - N Engl J Med
The documents contained in this website are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.